Budapest, Hungary

Zoltán Kazsu

This inventor holds 1 USPTO granted patent. Top assignees: Richter Gedeon Nyrt., Sumitomo Pharma Co., Ltd.. Active years: 2026.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Zoltán Kazsu: Innovator in Pharmaceutical Chemistry

Introduction

Zoltán Kazsu is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patent work. His expertise and dedication to research have led to advancements in drug formulation and delivery.

Latest Patents

Zoltán Kazsu holds a patent for "Crystalline solvated forms of N-(4-(1-(2,6-difluorobenzyl)-5-((dimethylamino)methyl)-3-(6-methoxy-3-pyridazinyl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-N'-methoxyurea." This disclosure relates to crystalline solvated forms of the compound, methods of making these forms, pharmaceutical compositions, and kits that include the forms. It also covers methods of treatment and uses involving their administration.

Career Highlights

Throughout his career, Zoltán Kazsu has worked with prominent companies in the pharmaceutical industry. He has been associated with Sumitomo Pharma Co., Ltd. and Richter Gedeon Nyrt., where he has contributed to various research and development projects. His work has been instrumental in advancing pharmaceutical formulations and improving patient outcomes.

Collaborations

Zoltán has collaborated with several professionals in his field, including Michael Thomas Brandl and Jennifer Nelson. These collaborations have fostered innovation and have led to the successful development of new pharmaceutical solutions.

Conclusion

Zoltán Kazsu is a distinguished inventor whose work in pharmaceutical chemistry has made a significant impact. His innovative patents and collaborations highlight his commitment to advancing healthcare through scientific research. His contributions continue to influence the industry and improve therapeutic options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…